FDA approves Qysmia, FDA bans BPA, Big babies and Breast Cancer
FDA approves Qysmia
|Updated: 7/18/2012 5:50 pm
||Published: 7/18/2012 5:47 pm
The FDA approves Qsymia.
The drug is expected to help overweight people drop about 10% of their weight.
Qsymia was denied approval in 2010 because of potential side effects.
In fact, the FDA is stressing the drug must not be used during pregnancy - because it can harm the fetus.
It's also not recommended for people with glaucoma or hyper Thyroidism - because it can boost the heart rate.
FDA bans BPA
A busy day for the FDA - the agency also officially banned using BPA in certain baby products.
Bisphenol-A is a chemical used in many products, including cans and clear plastic bottles.
FDA regulations now prohibit the use of BPA in making baby bottles, sippy cups and cans containing infant formula.
Most manufacturers have already stopped using BPA in baby products over concerns about health problems linked to the chemical.
Big babies and breast cancer
Delivering a big baby may increase your chances of developing breast cancer later in life.
Researchers found women who delivered babies weighing more than eight and a quarter pounds were more than twice as likely to develop breast cancer.
This suggests the body retains the memory of exposure to these hormones long after the pregnancy ends.
However, more research is needed before making clinical recommendations.
Copyright 2012 Newport Television LLC All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.